A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Alzheimer Disease
Related studies linked through entity extraction aliases.
Music for Pain and Dementia
- Status
- RECRUITING
- Phase
- NA
A Study of LY3439539 in Participants With Alzheimer's Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
REPAIR Sleep Study
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Effect of Scene-Based Training on Cognitive Function in Patients With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- NA
Retinal Hyperspectral Imaging in Neurodegenerative Diseases
- Status
- RECRUITING
- Phase
- NA
Efficacy and Safety of Temporal Interference Stimulation on Cognitive Function in Patients With Early-Stage Alzheimer's Disease
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
Detecting Beta-amyloid in the Retina
- Status
- TERMINATED
- Phase
- NA
The Gut - PRO Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Tele-Savvy for Latino Caregivers
- Status
- RECRUITING
- Phase
- NA
Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Biomarker-based Trial of NPC-1 for Alzheimer's Pathology
- Status
- RECRUITING
- Phase
- PHASE2
Learning Amyloid and Tau Results
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Epidemiology and Biomarker Study in Alzheimer's Disease
- Status
- RECRUITING
- Phase
- PHASE3
Transcranial Magnetic Stimulation to Slow Down Cognitive Decline in Alzheimer's Disease
- Status
- RECRUITING
- Phase
- NA
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
- Status
- RECRUITING
- Phase
- PHASE3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Status
- RECRUITING
- Phase
- PHASE3
The Brain&Senses Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A